fda glp-1 warning letters september 2025 news issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading pharmaceutical ads Patients taking an experimental oral

Patients often experience faster results with tirzepatide, though side effects like nausea may occur during dose escalation

The same principle applies to your natural GLP-1: even if your gut is producing plenty of it, a less sensitive receptor means the signal doesn't land as powerfully

Paradoxically, whilst long-term weight loss typically improves joint health and reduces osteoarthritis symptoms (as noted in NICE NG226), the transition period may be associated with adjustment-related discomfort

Weight loss plateaus Every patient on a GLP-1 will eventually stop losing weight

The purpose of this study was to investigate how vascular GLP-1 receptor expression is influenced in human subjects